Ipidacrine; 62732-44-9; Amiridine; 2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinolin-9-ylamine; 2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinolin-9-amine; Ipidacrine [INN]; CV71VTP0VN; 9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline; 1H-Cyclopenta(b)quinolin-9-amine, 2,3,5,6,7,8-hexahydro-; 1H,2H,3H,5H,6H,7H,8H-CYCLOPENTA[B]QUINOLIN-9-AMINE; CHEMBL130880; 2,3,5,6,7,8-Hexahydro-1H-cyclopenta(b)quinolin-9-amine; 1H-Cyclopenta[b]quinolin-9-amine, 2,3,5,6,7,8-hexahydro-, monohydrochloride- [CAS]; 9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinoline; 1H-CYCLOPENTA[B]QUINOLIN-9-AMINE, 2,3,5,6,7,8-HEXAHYDRO-; SMR000449322; UNII-CV71VTP0VN; BRN 0475930; CPD000449322; IPIDACRINE [MI]; IPIDACRINE [MART.]; IPIDACRINE [WHO-DD]; Oprea1_177774; Oprea1_388798; SCHEMBL28251; CBDivE_008152; MLS000758231; MLS001423960; DTXSID7048299; NIK(c)\\247; CHEBI:125612; HMS1685B19; HMS2051C11; HMS2232L05; HMS3393C11; (non-Isotopelabelled)Ipidacrine-d6; ZINC6780651; BBL003609; BDBM50279987; MFCD00618424; STK520619; AKOS000663960; CCG-100784; DB13668; HY-W027553; MB01346; NC00034; AS-37850; DB-073181; CS-0071577; FT-0601640; EN300-40535; VU0254176-6; BRD-K66896231-001-06-5; Q15409425; Z56766574; F6170-0039; 2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinoline-9-amine; 9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopent[b]quinoline; 1H-Cyclopenta(b)quinoline, 2,3,5,6,7,8-hexahydro-9-amino-; 9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]-quinoline